Exploiting nanotechnology to target cancer.
Nanotechnology is increasingly finding use in the management of cancer. Nanoscale devices have impacted cancer biology at three levels: early detection using, for example, nanocantilevers or nanoparticles; tumour imaging using radiocontrast nanoparticles or quantum dots; and drug delivery using nanovectors and hybrid nanoparticles. This review addresses some of the major milestones in the integration of nanotechnology and cancer biology, and the future of nanoscale approaches for cancer management.
Sengupta
S
S
BWH-HST Center for Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Cambridge, MA 02139, USA. shiladit@MIT.edu
Sasisekharan
R
R
D000970:Antineoplastic Agents / Q000627:therapeutic use; D015374:Biosensing Techniques; D006801:Humans; D008855:Microscopy, Electron, Scanning; D036103:Nanotechnology / Q000379:methods*; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*
D000970:Antineoplastic Agents